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Background
The t(8;21) translocation is one of the most frequent chro-
mosome abnormalities associated with acute myeloid leu-
kemia (AML). This translocation generates the (AML1/
MTG8) fusion protein causing blockage of the differentia-
tion process. Moreover, constitutive activation of the mito-
gen-activated protein kinase (MAPK) pathway as a
consequence of this translocation results in an increase in
the proliferation rate of leukemic cells.
Materials and methods
To ensure subsequent experiments are clinically relevant,
we carried out microarray on clinical samples from
patients who manifested the t(8;21) translocation together
with the corresponding cell lines (Kasumi-1 and SKNO-1).
We carried out microarray, qRT-PCR, gene knockdown
by siRNA, flowcytometry and various cell assays for apop-
tosis and cellular proliferation testing.
Results
Analyses revealed a number of overlapping differentially
expressed genes in the AML clinical samples and their
corresponding cell lines. These genes were uploaded to
the KEGG database through the DAVID software (v6.7) to
carry out pathway analyses of these leukemic cells.
Furthermore, gene expression profiles of both clinical
samples and their relevant cell lines showed increased
expression of AML1/MTG8 and ERK2 (MAPK1).
Using 100 nM and 200 nM of ERK2-siRNA and siRNA-
AML1/MTG8, respectively, siRNAs were transfected by
electroporation to knockdown ERK2 and the fusion gene
AML1/MTG8 individually and in combination in the
t(8;21) cell lines. Gene knockdowns were validated by
qRT-PCR, and demonstrated successful mRNA suppres-
sion by approximately 80% to 90%. In addition, a slight
increase of ERK2 mRNA expression was observed upon
AML1/MTG8 suppression.
FACS experiments showed reduced expression of
CD34 cell surface marker when AML1/MTG8 was
knocked down, which indicated onset of the differentia-
tion process whereas the ERK2 suppression displayed
higher CD34 expression when compared with mock and
siRNA controls, indicating an antidifferentiation effect.
Cell cycle analyses demonstrated increased growth arrest
where G0/G1 phase increased by 10% to 15% individually
and 25% to 30% in a combination, which correlated with
the MTS assay results. An apoptosis assay revealed anti-
apoptotic effect of ERK2 and AML1/MTG8 suppression,
which was increased when silenced together in a combi-
nation silencing.
A subsequent microarray experiment on cell lines with
these silenced genes was consistent with previous results
and disclosed several genes that might be involved in con-
trolling these processes.
Conclusions
These results suggest possible roles of ERK2 activation in
differentiation induction, while ERK2 inhibition arrested
cell growth and reduced proliferating cells in t(8;21) leuke-
mia when combined with AML1/MTG8 knockdown.
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